Skip to main content
NCBI home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2008 Dec;69(6):480–487. doi: 10.1016/j.curtheres.2008.12.002

Effect of equivalent doses of fentanyl, sufentanil, and remifentanil on the incidence and severity of cough in patients undergoing abdominal surgery: A prospective, randomized, double-blind study

Jin-Chun Shen 1, Jian-Guo Xu 1, Zhi-Qiang Zhou 1, Hong-Jun Liu 1, Jian-Jun Yang 1,*
PMCID: PMC3969975  PMID: 24692822

Abstract

Background: Fentanyl congeners have been found to induce cough during induction of general anesthesia. Studies of fentanyl and sufentanil have found incidence rates of 28% to 65% and 15%, respectively. However, no study has assessed the occurrence of cough induced by remifentanil.

Objective: The aim of this study was to assess the effect of equivalent doses of fentanyl, sufentanil, and remifentanil on cough.

Methods: Patients rated American Society of Anesthesiologists class I or II of either sex, aged 18 to 60 years, who were scheduled for elective abdominal surgery with general anesthesia were randomly and equally assigned to 3 groups using a computer-generated table of random numbers. The patients received equivalent doses of fentanyl 2 μg/kg, sufentanil 0.2 μg/kg, or remifentanil 2 μg/kg via IV push. Vital signs (systolic blood pressure [SBP], heart rate [HR], and oxygen saturation via pulse oximetry [SpO2]) and the occurrence and severity of cough were recorded for 2 minutes after drug administration by an anesthesiologist who was blinded to the drug treatment. The severity of cough was graded as none (0), mild (1–2), moderate (3–5), or severe (>5).

Results: A total of 315 Chinese patients (197 women, 118 men; mean [SD] age, 37.9 [10.4] years) were approached for enrollment and assigned to 3 groups of 105 patients each; all patients completed the study protocol. The 3 treatment groups were similar in terms of demographic characteristics and type of abdominal surgery. The incidence of cough was significantly greater in the remifentanil group (57 [54.3%] patients) than in the fentanyl group (35 [33.3%]; P < 0.01) or the sufentanil group (32 [30.5%]; P < 0.01). The severity of cough was significantly greater in the remifentanil group (severe, moderate, mild, none: 24, 7, 26, 48) than in the fentanyl (7, 9, 19, 70; P < 0.01) or sufentanil group (4, 2, 26, 73; P < 0.01). In all 3 groups, when the patients coughed, significant increases were observed in their SBP (128 [12]–139 [16] mm Hg; P < 0.01) and HR (74 [10]–87 [16] beats/min; P < 0.01). Within 2 minutes after drug administration, 62 patients (59%) in the remifentanil group experienced hypoxemia (SpO2 <90%) necessitating manually assisted mask ventilation, while no patients experienced hypoxemia in the fentanyl or sufentanil group. Three patients (2.9%) in the remifentanil group experienced muscle rigidity and deterioration of SBP, HR, and SpO2. No other adverse events were recorded.

Cunclusion: Remifentanil was associated with a significantly greater incidence and severity of cough than equivalent doses of fentanyl or sufentanil. Fentanyl and sufentanil appeared comparable in these Chinese patients undergoing abdominal surgery.

Key words: cough, incidence, severity, fentanyl, sufentanil, remifentanil

Full Text

The Full Text of this article is available as a PDF (657.2 KB).

References

  • 1.Lin CS, Sun WZ, Chan WH. Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough. Can J Anaesth. 2004;51:654–659. doi: 10.1007/BF03018421. [DOI] [PubMed] [Google Scholar]
  • 2.Agarwal A, Azim A, Ambesh S. Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by IV fentanyl. Can J Anaesth. 2003;50:297–300. doi: 10.1007/BF03017801. [DOI] [PubMed] [Google Scholar]
  • 3.Phua WT, Teh BT, Jong W. Tussive effect of a fentanyl bolus. Can J Anaesth. 1991;38:330–334. doi: 10.1007/BF03007623. [DOI] [PubMed] [Google Scholar]
  • 4.Böhrer H, Fleischer F, Werning P. Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia. 1990;45:18–21. doi: 10.1111/j.1365-2044.1990.tb14496.x. [DOI] [PubMed] [Google Scholar]
  • 5.Agarwal A, Gautam S, Nath SS. Comparison of the incidence and severity of cough induced by sufentanil and fentanyl: A prospective, randomised, double-blind study. Anaesthesia. 2007;62:1230–1232. doi: 10.1111/j.1365-2044.2007.05249.x. [DOI] [PubMed] [Google Scholar]
  • 6.Fukuda K. Intravenous opioid anesthetics. In: Miller RD, editor. Miller's Anesthesia. 6th ed. Churchill Livingstone Inc; New York, NY: 2005. pp. 379–438. [Google Scholar]
  • 7.McEwan AI, Smith C, Dyar O. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology. 1993;78:864–869. doi: 10.1097/00000542-199305000-00009. [DOI] [PubMed] [Google Scholar]
  • 8.Brunner MD, Braithwaite P, Jhaveri R. MAC reduction of isoflurane by sufentanil. Br J Anaesth. 1994;72:42–46. doi: 10.1093/bja/72.1.42. [DOI] [PubMed] [Google Scholar]
  • 9.Lang E, Kapila A, Shlugman D. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology. 1996;85:721–728. doi: 10.1097/00000542-199610000-00006. [DOI] [PubMed] [Google Scholar]
  • 10.Reitan JA, Stengert KB, Wymore ML, Martucci RW. Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesth Analg. 1978;57:31–36. doi: 10.1213/00000539-197801000-00007. [DOI] [PubMed] [Google Scholar]
  • 11.Inoue K, Samodelov LF, Arndt JO. Fentanyl activates a particular population of vagal efferents which are cardioinhibitory. Naunyn Schmiedebergs Arch Pharmacol. 1980;312:57–61. doi: 10.1007/BF00502575. [DOI] [PubMed] [Google Scholar]
  • 12.Karlsson JA, Sant'Ambrogio G, Widdicombe J. Afferent neural pathways in cough and reflex bronchoconstriction. J Appl Physiol. 1988;65:1007–1023. doi: 10.1152/jappl.1988.65.3.1007. [DOI] [PubMed] [Google Scholar]
  • 13.Benthuysen JL, Smith NT, Sanford TJ. Physiology of alfentanil-induced rigidity. Anesthesiology. 1986;64:440–446. doi: 10.1097/00000542-198604000-00005. [DOI] [PubMed] [Google Scholar]
  • 14.Pandey CK, Raza M, Ranjan R. Intravenous lidocaine 0.5 mg·kg−1 effectively suppresses fentanyl-induced cough. Can J Anaesth. 2005;52:172–175. doi: 10.1007/BF03027724. [DOI] [PubMed] [Google Scholar]
  • 15.Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:53–63. doi: 10.1097/00000542-199101000-00010. [DOI] [PubMed] [Google Scholar]
  • 16.Metz C, Göbel L, Gruber M. Pharmacokinetics of human cerebral opioid extraction: A comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury. Anesthesiology. 2000;92:1559–1567. doi: 10.1097/00000542-200006000-00012. [DOI] [PubMed] [Google Scholar]
  • 17.Haber GW, Litman RS. Generalized tonic-clonic activity after remifentanil administration. Anesth Analg. 2001;93:1532–1533. doi: 10.1097/00000539-200112000-00040. [DOI] [PubMed] [Google Scholar]
  • 18.James MK, Vuong A, Grizzle MK. Hemodynamic effects of Gl 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther. 1992;263:84–91. [PubMed] [Google Scholar]
  • 19.Fodale V, Schifilliti D, Praticò C, Santamaria LB. Remifentanil and the brain. Acta Anaesthesiol Scand. 2008;52:319–326. doi: 10.1111/j.1399-6576.2007.01566.x. [DOI] [PubMed] [Google Scholar]
  • 20.Thomson IR, Putnins CL, Friesen RM. Hyperdynamic cardiovascular responses to anesthetic induction with high-dose fentanyl. Anesth Analg. 1986;65:91–95. [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES